Photofunctionalization and Hyaluronic Acid for Posterior Maxillary Implants

N/AActive Not RecruitingNCT07700732

Mansoura University60 enrolled

Overview

This randomized clinical trial evaluates the effect of UV photofunctionalization and hyaluronic acid on dental implants placed in the posterior maxilla. Clinical and radiographic outcomes will be assessed during follow-up

The study compares conventional implants, UV-photofunctionalized implants, and UV-photofunctionalized implants with hyaluronic acid application in the posterior maxilla. Implant stability and peri-implant tissue changes will be evaluated clinically and radiographically during follow-up.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Tooth Loss Surface Treatment Delayed Implant Implant Placement UV Dental Implant Hyaluronic Acid (HA)

Interventions

Delayed dental implant placement without photofunctionalization.PROCEDURE

Delayed dental implants placed without photofunctionalization or hyaluronic acid in the posterior maxilla.

Delayed dental Implant photofunctionalization before placementPROCEDURE

Delayed dental implants photofunctionalized with UV light before placement in the posterior maxilla.

Delayed dental Implant photofunctionalization and hyaluronic acid application before placement.PROCEDURE

Delayed dental implants photofunctionalized with UV light and treated with hyaluronic acid before placement in the posterior maxilla.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with missed single tooth or multiple teeth in posterior maxilla. * Patients Free from any para-functional habits. * Patient with Adequate inter-arch relation and inter-occlusal space to accommodate the prosthetic restoration. * Patient with good oral hygiene. * Patients Willing to participate in the study's follow-up intervals. Exclusion Criteria: * Patients with any local or systemic disease that absolute contraindicate implant placement or surgery. * Pregnancy. * Patients with any pathological lesion or aggressive periodontal disease at the planned surgical site. * Patients on drugs that could affect bone healing process such as bisphosphonate. * Heavy Smokers for more than 10 cigarettes a day. * Uncooperative patients.

Locations (1)

Faculty of Dentistry Mansoura University

Al Mansurah, Egypt

Outcomes

Primary Outcomes

Hard Tissue (peri-implant bone)

Marginal bone loss will be assessed using CBCT measured in mm.

Time frame: - Immediately postoperative - 3 months after implant placement - 9 months after implant placement.

Implant Stability

Implant stability will be evaluated using Osstell device based on resonance frequency analysis (ISQ values).

Time frame: -immediately after implant placement -2 weeks postoperatively -4 weeks postoperatively - 3 months postoperatively - 9 months postoperatively

Secondary Outcomes

Soft Tissue

The peri-implant mucosa will be evaluated for signs of inflammation using the Modified Sulcus Bleeding Index (mSBI).

Time frame: -After 3 months postoperatively. -After 9 months postoperatively.

Peri-implant probing depth

Probing depth will be assessed using a calibrated periodontal probe and measured in mm.

Time frame: After 3 months postoperatively. -After 9 months postoperatively.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.